📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. (2019)

First Author: Reynolds JA

Attributed to: Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13075-019-1929-4

PubMed Identifier: 31200750

Publication URI: http://europepmc.org/abstract/MED/31200750

Type: Journal Article/Review

Volume: 21

Parent Publication: Arthritis research & therapy

Issue: 1

ISSN: 1478-6354